These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 3062906
1. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication]. Rudofsky G. Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906 [Abstract] [Full Text] [Related]
2. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study. Caspary L, Creutzig A, Radeke U, Specht S, Alexander K. Biomed Biochim Acta; 1988 Jul 15; 47(10-11):S307-10. PubMed ID: 3073766 [Abstract] [Full Text] [Related]
3. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication. Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F. Int J Clin Pharmacol Ther; 1999 Jul 15; 37(7):347-51. PubMed ID: 10442509 [Abstract] [Full Text] [Related]
4. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates]. Creutzig A, Caspary L, Radeke U, Specht S, Alexander K. Vasa Suppl; 1988 Jul 15; 23():133-5. PubMed ID: 3061036 [No Abstract] [Full Text] [Related]
5. PoleStriding exercise and vitamin E for management of peripheral vascular disease. Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN. Med Sci Sports Exerc; 2003 Mar 15; 35(3):384-93. PubMed ID: 12618567 [Abstract] [Full Text] [Related]
6. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. Hood SC, Moher D, Barber GG. CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633 [Abstract] [Full Text] [Related]
7. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease]. Streminski JA, de la Haye R, Rettig K, Kuntz G. Vasa; 1992 Oct 15; 21(4):392-402. PubMed ID: 1485475 [Abstract] [Full Text] [Related]
8. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates]. Creutzig A, Caspary L, Radeke U, Specht S, Ranke C, Alexander K. Med Klin (Munich); 1988 Jun 17; 83(13-14):434-8. PubMed ID: 3062344 [No Abstract] [Full Text] [Related]
9. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial. Messa GL, Gelso E. Drugs Exp Clin Res; 2002 Jun 17; 28(1):37-48. PubMed ID: 12073766 [Abstract] [Full Text] [Related]
10. [Prostaglandin E1 in intermittent claudication]. Scheffler P, de la Hamette D, Rogatti W. Vasa Suppl; 1992 Jun 17; 35():147-8. PubMed ID: 1481022 [No Abstract] [Full Text] [Related]
11. [European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication]. Laurora G, Corsi M, Bucci M, Cesarone MR, Belcaro G, Dugall M. Minerva Cardioangiol; 1998 Oct 17; 46(10 Suppl 1):21-9. PubMed ID: 10658441 [Abstract] [Full Text] [Related]
12. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study. Diehm C, Kühn A, Strauss R, Hübsch-Müller C, Kübler W. Vasa Suppl; 1989 Oct 17; 28():26-30. PubMed ID: 2609241 [Abstract] [Full Text] [Related]
13. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study. Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group. Thromb Haemost; 2001 Nov 17; 86(5):1181-7. PubMed ID: 11816704 [Abstract] [Full Text] [Related]
14. Ketanserin in intermittent claudication. A double-blind placebo-controlled study. Clement DL, Duprez D, Van Wassenhove A, Brusselmans F. Int Angiol; 1989 Nov 17; 8(2):92-6. PubMed ID: 2681451 [Abstract] [Full Text] [Related]
15. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication]. Diehm C, Eckstein M, Hübsch-Müller C. Vasa; 1989 Nov 17; 18(1):40-7. PubMed ID: 2648691 [Abstract] [Full Text] [Related]
16. [Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication]. Schräder R, Nachbur B, Mahler F. Schweiz Med Wochenschr; 1985 Jun 01; 115(22):752-6. PubMed ID: 3892663 [Abstract] [Full Text] [Related]
17. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial. Arosio E, De Marchi S, Zannoni M, Prior M, Lechi A. Mayo Clin Proc; 2002 Aug 01; 77(8):754-9. PubMed ID: 12173710 [Abstract] [Full Text] [Related]
18. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication. Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS. Angiology; 2000 Jun 01; 51(6):441-9. PubMed ID: 10870853 [Abstract] [Full Text] [Related]
19. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC. J Am Coll Cardiol; 1998 Nov 01; 32(5):1336-44. PubMed ID: 9809945 [Abstract] [Full Text] [Related]
20. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Radack K, Deck C. Arch Intern Med; 1991 Sep 01; 151(9):1769-76. PubMed ID: 1679624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]